PHR
Get informed when a big investor buys or sells
+ FollowUndervalued by 197.3% based on the discounted cash flow analysis.
| Market cap | $620.59 Million |
|---|---|
| Enterprise Value | $648.84 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.04 |
| Beta | 0.86 |
| Outstanding Shares | 61,878,316 |
| P/E Ratio | 58.3 |
|---|---|
| PEG | 9.76 |
| Price to Sales | 1.25 |
| Price to Book Ratio | 1.67 |
| Enterprise Value to Revenue | 1.28 |
| Enterprise Value to EBIT | 77.13 |
| Enterprise Value to Net Income | -111 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.27 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2916▼ 317.68% |
|---|---|
| Total Calls | 402,600▲ 389.78% |
| Total Puts | 117,400▼ 58.82% |
Holdings and activity of institutional investors.
| Ownership % | 95.06%▼ 1.37% |
|---|---|
| Total Invested | $604.56M▲ 21.89% |
| Investors Holding | 237▼ 17.00% |
No data
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimi...